Product Information
ETHOSUXIMIDE 250 MG CAPSULE is a generic product labeled by Strides Pharma Inc., priced at $0.2523 per EA under NDC 64380087806. Its NADAC has been published 308 times since Aug 5, 2020.
Strength
250 mg/1
Manufacturer
Strides Pharma Inc.NDC
64380087806
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ETHOSUXIMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA211928On Market Since
5/15/2019
Pharmacological Classes
Price Statistics
The NADAC for ETHOSUXIMIDE 250 MG CAPSULE has been published 308 times since Aug 5, 2020, and over the history we have for it it has declined 65.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2523 per EA |
|---|---|
| All-time high | $0.7241 (Aug 12, 2020) |
| All-time low | $0.1798 (Nov 20, 2024) |
| 52-week high | $0.2649 |
| 52-week low | $0.2210 |
| Median price | $0.3552 |
| Average price | $0.3983 |
| Largest weekly change | +76.6% (Jan 19, 2022) |
| Weeks tracked | 308 |
| Tracking since | Aug 5, 2020 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ETHOSUXIMIDE 250 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ETHOSUXIMIDE 250 MG CAPSULE, manufactured by Strides Pharma Inc., is $0.2523 per EA (NDC 64380087806), effective Jun 24, 2026.
How has the price of ETHOSUXIMIDE 250 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has declined 65.1%. It has been tracked across 308 weekly CMS publications since Aug 5, 2020.
What are the highest and lowest recorded NADAC prices for ETHOSUXIMIDE 250 MG CAPSULE?
Since Aug 5, 2020, the NADAC for ETHOSUXIMIDE 250 MG CAPSULE has ranged from a low of $0.1798 (Nov 20, 2024) to a high of $0.7241 (Aug 12, 2020), with a median of $0.3552 per EA.
Are there cheaper alternatives to ETHOSUXIMIDE 250 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ETHOSUXIMIDE 250 MG CAPSULE, but none are currently priced below it.
Who manufactures ETHOSUXIMIDE 250 MG CAPSULE?
ETHOSUXIMIDE 250 MG CAPSULE (NDC 64380087806) is labeled by Strides Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification